Suppr超能文献

甲状腺功能减退症的隐匿危害:他汀类药物相关横纹肌溶解症及危及生命的并发症

The Hidden Hazard of Hypothyroidism: Statin-Associated Rhabdomyolysis With Life-Threatening Complications.

作者信息

Bechir George, Bechir Angelina

机构信息

Hospital Medicine, Franciscan Health Munster, Munster, USA.

Genetics, Clemson University, Clemson, USA.

出版信息

Cureus. 2025 Jun 7;17(6):e85506. doi: 10.7759/cureus.85506. eCollection 2025 Jun.

Abstract

Statins are among the most widely prescribed medications for reducing cardiovascular morbidity and mortality. While generally well tolerated, they carry a rare but potentially fatal risk of rhabdomyolysis - a condition marked by massive skeletal muscle breakdown, electrolyte abnormalities, and acute kidney injury (AKI). We report the case of a 76-year-old man who developed profound rhabdomyolysis, severe transaminitis, and dialysis, requiring AKI shortly after initiating atorvastatin. His initial symptoms included excruciating bilateral lower extremity pain and progressive weakness, ultimately rendering him unable to walk. Laboratory evaluation revealed a creatine kinase level exceeding 25,000 U/L, marked elevations in aspartate aminotransferase (AST) and alanine aminotransferase (ALT), and a creatinine of 9.6 mg/dL. Despite prompt initiation of aggressive intravenous hydration, bladder decompression, and supportive care, the patient remained anuric and progressed to volume overload, necessitating initiation of hemodialysis. Further evaluation revealed profoundly uncontrolled hypothyroidism, with a thyroid-stimulating hormone (TSH) of 121.7 µIU/mL and a free T4 level of less than 0.4 ng/dL, despite reported use of levothyroxine. MRI of the thigh showed diffuse muscular edema without myonecrosis, and an autoimmune myositis panel was negative. Atorvastatin was promptly discontinued, and thyroid hormone therapy was intensified. Over the next several days, his biochemical parameters slowly improved, and he was ultimately discharged to acute rehabilitation with plans for outpatient dialysis and endocrine follow-up. This case underscores the synergistic danger of statin therapy in the presence of untreated or undertreated hypothyroidism. Routine screening for thyroid dysfunction, particularly in elderly patients or those with known thyroid disease, may help prevent catastrophic complications such as rhabdomyolysis and irreversible renal injury.

摘要

他汀类药物是用于降低心血管疾病发病率和死亡率的最广泛处方药物之一。虽然通常耐受性良好,但它们存在一种罕见但可能致命的横纹肌溶解风险——一种以大量骨骼肌分解、电解质异常和急性肾损伤(AKI)为特征的病症。我们报告了一例76岁男性的病例,该患者在开始服用阿托伐他汀后不久就出现了严重的横纹肌溶解、严重的转氨酶升高和需要透析的急性肾损伤。他最初的症状包括双侧下肢剧痛和进行性无力,最终导致他无法行走。实验室检查显示肌酸激酶水平超过25,000 U/L,天冬氨酸转氨酶(AST)和丙氨酸转氨酶(ALT)显著升高,肌酐为9.6 mg/dL。尽管迅速开始积极的静脉补液、膀胱减压和支持治疗,但患者仍无尿,并进展为容量超负荷,需要开始血液透析。进一步评估发现甲状腺功能减退严重失控,尽管报告使用了左甲状腺素,但促甲状腺激素(TSH)为121.7 μIU/mL,游离T4水平低于0.4 ng/dL。大腿MRI显示弥漫性肌肉水肿但无肌坏死,自身免疫性肌炎检查结果为阴性。阿托伐他汀立即停用,并加强甲状腺激素治疗。在接下来的几天里,他的生化指标逐渐改善,最终出院接受急性康复治疗,并计划进行门诊透析和内分泌随访。该病例强调了在存在未治疗或治疗不足的甲状腺功能减退情况下他汀类药物治疗的协同危险。常规筛查甲状腺功能障碍,特别是在老年患者或已知甲状腺疾病的患者中,可能有助于预防诸如横纹肌溶解和不可逆肾损伤等灾难性并发症。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/79fd/12145068/5a450d561e0d/cureus-0017-00000085506-i01.jpg

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验